Recursion reports second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million. Recursion reports a second-quarter loss of 41 cents per share, missing estimates for a loss of 34 cents per share. The market's back, and these 3 income stocks are thriving. See them here→

RXRX

<p>Recursion 報告第二季度收入為 1922 萬美元，超出分析師預期的 1623 萬美元。Recursion 報告第二季度每股虧損 41 美分，未能達到預期的每股虧損 34 美分。市場回暖，這三隻收益股票表現良好。點擊這裏查看→</p>

Recursion Pharmaceuticals 報告第二季度虧損大於預期，但收入超過預期